CDNA
Diagnostics & Research · Healthcare
CEO, Board Member
2020-01-01–2023-11-01
Equibles does not estimate personal net worth.
Reginald Seeto was last confirmed as CEO at CareDx, Inc. (CDNA) in a filing dated April 29, 2024. Earlier roles on record: CEO and Board Member at CareDx, Inc. (CDNA) until November 1, 2023. The proxy statement of CareDx, Inc. reports total compensation of $7,090,121 for Reginald Seeto in fiscal 2021, including a base salary of $540,000. Disclosed compensation is on record for 4 fiscal years. Reginald Seeto has spoken on 6 earnings calls across 1 company, most recently for CareDx, Inc. on February 27, 2023. The companies whose calls Reginald Seeto spoke on are classified in the Healthcare sector.
“During 2022 the company made significant progress towards our vision of being the leader in the transplant ecosystem, while delivering on our mission to bring innovation across the transplant patient journey.”
“We had a very strong start to the year with a record first quarter result. Our vision of being leader in the transplant ecosystem continues to resonate as we remain focused on the transplant patient.”
“Before getting into our results, I want to thank all of our CareDx employees and partners. Despite the many challenges of 2020 with COVID-19, all of us at CareDx rallied together and worked tirelessly to develop and deliver new and unique solutions to improve transplant patient lives.”
“Firstly, I want to thank Peter for his dedication and leadership in building KTXA on its IPO to where it is today. It truly is a special place to help shape and build.”
“I've seen a stunning success with new centers and patients, as well as an increase in adherence. Peter mentioned that this is based on a full-month experience, showing consistent trends across the over a thousand patients enrolled in the program.”
2020-01-01–2023-11-01
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Proxy statement
Start not stated–2020-04-29
Last confirmed by a filing; no departure on record
Start not stated–2023-11-01
CDNA
Diagnostics & Research · Healthcare
CEO, Board Member
2020-01-01–2023-11-01
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | CareDx, Inc. (CDNA) | MBBS Chief Executive Officer and President | $540,000 | $7,090,121 |
| 2020 | CareDx, Inc. (CDNA) | MBBS Chief Executive Officer and President | $429,167 | $5,618,698 |
| 2019 | CareDx, Inc. (CDNA) | MBBS Chief Executive Officer and President | $400,000 | $1,955,661 |
| 2018 | CareDx, Inc. (CDNA) | MBBS Chief Executive Officer, President and Chief Business Officer | $40,909 | $3,168,380 |